All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Thu 1972-06-01? to Mon 2025-05-12 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| BMY × |
−12.94%
2025-05-12 |
180.79 TR
2025-05-12 |
||||
| Bristol-Myers Squibb Company NYSE Common Stock | ||||||
| Thu 1972-06-01? to Mon 2025-05-12 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| BMY × |
+17,978.80%
+10.31%/yr |
+11.71%/yr
(R2=0.916) |
||||
| Bristol-Myers Squibb Company NYSE Common Stock | ||||||
| Thu 1972-06-01? to Mon 2025-05-12 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| BMY × |
$10,000.00
1972-06-01 |
$1,807,879.92
2025-05-12 |
||||
| Bristol-Myers Squibb Company NYSE Common Stock | ||||||
| Year | BMY |
|---|---|
| 2025 (YTD) | −12.94% |
| 2024 | +15.81% |
| 2023 | −26.14% |
| 2022 | +18.98% |
| 2021 | +2.88% |
| 2020 | +0.41% |
| 2019 | +27.74% |
| 2018 | −12.90% |
| 2017 | +7.71% |
| 2016 | −13.49% |
| 2015 | +19.26% |
| 2014 | +14.18% |
| 2013 | +69.96% |
| 2012 | −3.80% |
| 2011 | +39.44% |
| 2010 | +8.74% |
| 2009 | +14.82% |
| 2008 | −6.03% |
| 2007 | +4.79% |
| 2006 | +19.90% |
| 2005 | −6.14% |
| 2004 | −7.24% |
| 2003 | +29.14% |
| 2002 | −52.40% |
| 2001 | −26.16% |
| 2000 | +17.10% |
| 1999 | −2.79% |
| 1998 | +43.03% |
| 1997 | +77.25% |
| 1996 | +36.90% |
| 1995 | +53.55% |
| 1994 | +6.47% |
| 1993 | −9.22% |
| 1992 | −21.05% |
| 1991 | +36.06% |
| 1990 | +24.31% |
| 1989 | +28.94% |
| 1988 | +14.36% |
| 1987 | +2.84% |
| 1986 | +35.83% |
| 1985 | +30.58% |
| 1984 | +28.17% |
| 1983 | +30.54% |
| 1982 | +31.21% |
| 1981 | +9.16% |
| 1980 | +40.53% |
| 1979 | +7.87% |
| 1978 | +10.24% |
| 1977 | +1.34% |
| 1976 | +2.08% |
| 1975 | +41.00% |
| 1974 | +11.80% |
| 1973 | −30.94% |
| 1972 | +10.96% |
| Thu 1972-06-01? to Mon 2025-05-12 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| BMY × | −33.97% |
−70.62%
2002-07-24 |
||||
| Bristol-Myers Squibb Company NYSE Common Stock | ||||||